Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

GNE-7883 is an allosteric pan-TEA domain transcription factor (pan-TEAD) inhibitor.1 It binds to the lipid-binding pockets of TEAD1-4 (IC50s = 0.01-0.05 µM) and inhibits the protein-protein interactions between TEAD1-4 and YAP (IC50s = 0.01-0.09 µM) and between TEAD1-4 and TAZ (IC50s = 0.01-0.1 µM). GNE-7883 inhibits the proliferation of YAP-amplified OVCAR-8 ovarian cancer and NF2-null HCC1576 adrenocortical carcinoma cells (IC50s = 0.17 and 0.29 µM, respectively). In vivo, GNE-7883 (250 mg/kg) reduces tumor volume in NCI H226 lung cancer and MSTO-211H mesothelioma mouse xenograft models. It also resensitizes sotorasib-resistant NCI H358 non-small cell lung cancer (NSCLC) cells to the K-RasG12C inhibitor sotorasib (AMG 510; Item No. 29465) in a mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. An allosteric pan-